Wang X, hui yang, Wang S, Hu X, Yu X, Wang W, et al. Comparison of effectiveness and safety outcomes of abiraterone versus enzalutamide in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis: Abiraterone versus enzalutamide in mCRPC. J Pharm Pharm Sci [Internet]. 2020 Nov. 20 [cited 2024 Jul. 9];23:451-6. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31003